Teva Pharmaceutical Industries Limited : Teva to Present at the 2012 RBC Capital Markets' Global Healthcare Conference
02/28/2012| 08:40am US/Eastern
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) will host a live
audio webcast at the 2012 RBC Capital Markets' Global Healthcare
Conference in New York. Lesley Russell, SVP, R&D Global Branded
Products, will present on Wednesday, February 29, 2012.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) is a leading global
pharmaceutical company, committed to increasing access to high-quality
healthcare by developing, producing and marketing affordable generic
drugs as well as innovative and specialty pharmaceuticals and active
pharmaceutical ingredients. Headquartered in Israel, Teva is the world's
largest generic drug maker, with a global product portfolio of more than
1,300 molecules and a direct presence in about 60 countries. Teva's
branded businesses focus on CNS, oncology, pain, respiratory and women's
health therapeutic areas as well as biologics. Teva currently employs
approximately 46,000 people around the world and reached $18.3 billion
in net revenues in 2011.
Teva Pharmaceutical Industries Ltd.
C. Mannix, 215-591-8912 (United States)
972 (3) 926-7656 (Israel)
215-591-8974 (United States)
Shir Altay-Hagoel, 972 (3)
© Business Wire 2012